anybody have any info on company who's going to handle pfizer vaksin.. my opinion is pharma niaga is one of the company n Pharmaniaga is owned by Boustead Holdings and the Armed Forces Fund Board, LTAT. If this is true, bousted will fly like hell
Locally bottled vaccine ....1 bottle profits let say min rm10 nett profits minus expenses ...1 person or newborn baby needs 2 bottles ..so rm20 x 33 mil = ? ...anyone good in maths lolzzzz hahahha
Bouestead NEEDS to have a TAKEOVER syndicate for it to REALLY move. LTAT being the MAIN shares HOLDER are in NEED of lots of $$$$$$. If Syndicate can make a unconditional offer of rm 1.74 ( based on 4Q2020) results then , the counter MAY move and GOVN may FORCE LTAT to CASH OUT ! Else LTAT ( due to politicians control ) will NOT SELL. See if DUMNO and Berstaru can settle it . ;-)
PN prepared to sell and let go its government control assets. CANCELLATION of HSR raillink may caused Malaysia to compensate Singapore 837 Million { SGD 270 million}
Pharmaniaga to produce 2 mil doses of Sinovac vaccine a month Bernama - January 12, 2021 3:32 PM 1.7k Shares facebook
Guests at the agreement signing ceremony between Pharmaniaga Bhd and Sinovac Life Sciences Co Ltd in Kuala Lumpur today. (Bernama pic) KUALA LUMPUR: Pharmaniaga Bhd has the capacity to manufacture two million doses of Covid-19 vaccine developed by China’s Sinovac Life Sciences Co Ltd a month beginning in March.
Its group managing director, Zulkarnain Md Eusope, said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga’s wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.
He said the group would invest RM3 million to retrofit the plant to enable the production of the vaccine.
“We are confident of carrying out the task successfully because our technical experts have been working on the setting up of a halal vaccine plant in Malaysia since 2017,” he told reporters after the signing of an agreement between Pharmaniaga and Sinovac today
“When Covid-19 spread around the world early last year, we immediately channelled our team to work with our global partners, including Sinovac, on the fill and finish manufacturing activity and technology transfer to speed up the availability of vaccines against the pandemic.”
The signing ceremony was witnessed by senior minister for security Ismail Sabri Yaakob, health minister Dr Adham Baba and science, technology and innovation minister Khairy Jamaluddin.
The agreement is for the supply of 14 million doses of Covid-19 vaccine to be carried out through the fill and finish activity.
Pharmaniaga has been engaging with the National Pharmaceutical Regulatory Agency (NPRA) to ensure that its plant continues to be in high compliance with regulatory requirements.
Pharmaniaga Berhad is not owned by hedge funds. The company's largest shareholder is Boustead Holdings Berhad, with ownership of 56%, This implies that they have majority interest control of the future of the company. The second and third largest shareholders are Lembaga Tabung Angkatan Tentera (LTAT) and Che bin Wok Kamaruddin, holding 11% and 4.8%, respectively.
Bousteadinvestor .Food for thought .Syed Mokthar low profile billionaire { MMC & DRB } fame was seen as prime candidate to acquire a stalk in the FGV saga. due to timing and change of government { Felda decided to take FGV private } A big if ? Is the buyer { Syed Mokthar or related parties } acquired the shares 25000000 ? I don't have the answer
Boutead new MD { shazalli ramli} & LTAT new CEO { amrin awaluddin} have to prove themselves worthy of the appointments. Amrin is former Boustead MD { before taking up LTAT CEO position}
Boustead now trading half of it's last traded price 1.22 ( April 2019 } and against its NTA of 1.89. against privatised proposal of 80 sen { a real bargain for LTAT } compared to the low CPO prices in 2018/2019
i wonder if investors would reject any offer by pushing the share above the offer price. 80c is too low IMHO. Someone should call Dr Yu Kuan Chong and do another HLCAP
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Solomon7
370 posts
Posted by Solomon7 > 2021-01-06 20:25 | Report Abuse
After tonight, would it rocket up soon